Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 27, 2025
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has notified BSE and NSE that its 40th Annual General Meeting (AGM) will be held on Saturday, 27th September 2025 at 3:00 PM via Video Conferencing. Shareholders will consider adoption of audited financial statements for FY ended March 31, 2025, and re-appointment of Mr. Meet Shah who retires by rotation. Special business includes appointing Joshi Sahay and Company as Secretarial Auditor for five years (FY 2025-26 to FY 2029-30), re-appointing independent directors Mr. Ashok Kumar Ramawat and Mr. Satish Beohar for second terms of five years each, and approving material related party transactions with Cyano Pharma Private Limited worth up to INR 35 Crores for FY 2025-26. Additionally, members will vote on changing Mr. Ketan Shah's designation from Whole Time Director to Chairman and Managing Director for three years (salary up to Rs. 2.50 lakh per month), and confirming the appointment of Mr. Smitesh Shah as Promoter Non-Executive Non-Independent Director. The cut-off date for e-voting eligibility is 20th September 2025, with remote e-voting open from 24th to 26th September 2025.
Shareholders should mark 27th September 2025 on their calendars and ensure e-voting between 24th-26th September 2025, as the meeting includes significant resolutions like a INR 35 Crore related party transaction with Cyano Pharma and a leadership change elevating Mr. Ketan Shah to Chairman and MD. The re-appointment of two independent directors for fresh five-year terms signals board continuity, while the new secretarial auditor appointment reflects routine governance compliance.